Literature DB >> 32209472

Lymph Node Stromal Cells Generate Antigen-Specific Regulatory T Cells and Control Autoreactive T and B Cell Responses.

Reza Nadafi1, Catarina Gago de Graça2, Eelco D Keuning2, Jasper J Koning2, Sander de Kivit3, Tanja Konijn2, Sandrine Henri4, Jannie Borst3, Rogier M Reijmers2, Lisa G M van Baarsen5, Reina E Mebius6.   

Abstract

Within lymph nodes (LNs), T follicular helper (TFH) cells help B cells to produce antibodies, which can either be protective or autoreactive. Here, we demonstrate that murine LN stromal cells (LNSCs) suppress the formation of autoreactive TFH cells in an antigen-specific manner, thereby significantly reducing germinal center B cell responses directed against the same self-antigen. Mechanistically, LNSCs express and present self-antigens in major histocompatibility complex (MHC) class II, leading to the conversion of naive CD4+ T cells into T regulatory (TREG) cells in an interleukin-2 (IL-2)-dependent manner. Upon blockade of TREG cells, using neutralizing IL-2 antibodies, autoreactive TFH cells are allowed to develop. We conclude that the continuous presentation of self-antigens by LNSCs is critical to generate antigen-specific TREG cells, thereby repressing the formation of TFH cells and germinal center B cell responses. Our findings uncover the ability of LNSCs to suppress the early activation of autoreactive immune cells and maintain peripheral tolerance.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cells; T follicular helper; T regulatory cells; Tolerance; lymph node stromal cells

Mesh:

Substances:

Year:  2020        PMID: 32209472     DOI: 10.1016/j.celrep.2020.03.007

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  20 in total

1.  Lymph Node Stromal Cell-Intrinsic MHC Class II Expression Promotes MHC Class I-Restricted CD8 T Cell Lineage Conversion to Regulatory CD4 T Cells.

Authors:  Amanda M Honan; Emily N Vazquez; Zhibin Chen
Journal:  J Immunol       Date:  2021-08-18       Impact factor: 5.426

2.  Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.

Authors:  Kevin MingJie Gao; Mona Motwani; Thomas Tedder; Ann Marshak-Rothstein; Katherine A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-13       Impact factor: 12.779

Review 3.  The lymphatic vasculature: An active and dynamic player in cancer progression.

Authors:  Sara Rezzola; Elena C Sigmund; Cornelia Halin; Roberto Ronca
Journal:  Med Res Rev       Date:  2021-09-05       Impact factor: 12.388

Review 4.  Stromal Cells Underlining the Paths From Autoimmunity, Inflammation to Cancer With Roles Beyond Structural and Nutritional Support.

Authors:  Amanda M Honan; Zhibin Chen
Journal:  Front Cell Dev Biol       Date:  2021-05-25

Review 5.  LN-Derived Fibroblastic Reticular Cells and Their Impact on T Cell Response-A Systematic Review.

Authors:  Bianca O Ferreira; Lionel F Gamarra; Mariana P Nucci; Fernando A Oliveira; Gabriel N A Rego; Luciana Marti
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

6.  Human Lymph Node Stromal Cells Have the Machinery to Regulate Peripheral Tolerance during Health and Rheumatoid Arthritis.

Authors:  Janine S Hähnlein; Reza Nadafi; Tineke A de Jong; Johanna F Semmelink; Ester B M Remmerswaal; Mary Safy; Krijn P van Lienden; Mario Maas; Danielle M Gerlag; Paul P Tak; Reina E Mebius; Heidi Wähämaa; Anca I Catrina; Lisa G M van Baarsen
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

Review 7.  Lymph Node Stromal Cells: Mapmakers of T Cell Immunity.

Authors:  Guillaume Harlé; Camille Kowalski; Laure Garnier; Stéphanie Hugues
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

Review 8.  Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant.

Authors:  Chang Yang; Bai-Rong Xia; Zhao-Cong Zhang; Yong-Jian Zhang; Ge Lou; Wei-Lin Jin
Journal:  Front Immunol       Date:  2020-10-06       Impact factor: 7.561

9.  The curious case of IL-33 in homeostasis and infection.

Authors:  Reza Nadafi; Ramon Arens
Journal:  Eur J Immunol       Date:  2020-12-17       Impact factor: 6.688

10.  Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation.

Authors:  Sushila A Toulmin; Chaitali Bhadiadra; Andrew J Paris; Jeffrey H Lin; Jeremy Katzen; Maria C Basil; Edward E Morrisey; G Scott Worthen; Laurence C Eisenlohr
Journal:  Nat Commun       Date:  2021-06-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.